Of these, HBEGF is abundantly expressed in human adipose tissue [30], TGFα has been implicated in the development of obesity-related postmenopausal breast cancer using rodent models [31], and EGF has received much attention as a therapeutic target in anticancer therapies [32]. Here, EGF is linked to breast cancer.